# US 2012/0252069 A1 · Process for the purification of glycoproteins

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252069 A1
- Document ID: US20120252069A1
- Status: Published application
- Kind: A1
- Application number: 13/511,285
- Filed: 2010-11-24
- Published: 2012-10-04
- Earliest claimed: 2009-11-24
- Assignees: Glycotope GmbH
- Inventors: Steffen Goletz; Lars Stockl
- Web page: https://patentgrep.com/patent/US20120252069A1

## CPC

- C07K 1/36: by a combination of two or more processes of different types
- C07K 14/59: Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g.hCG [human chorionic gonadotropin]; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
- C07K: PEPTIDES (peptides in foodstuffs A23; obtaining protein compositions for foodstuffs, working-up proteins for foodstuffs A23J; preparations for medicinal purposes A61K; peptides containing beta-lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D519/02; macromolecular compounds having statistically distributed amino acid units in their molecules, i.e. when the preparation does not provide for a specific; but for a random sequence of the amino acid units, homopolyamides and block copolyamides derived from amino acids C08G69/00; macromolecular products derived from proteins C08H1/00; preparation of glue or gelatine C09H; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N15/00; compositions for measuring or testing processes involving enzymes C12Q; investigation or analysis of biological material G01N33/00)

## Abstract

The present invention relates to a process for the purification of a glycoprotein comprising subjecting a liquid containing said glycoprotein to the steps of: a) reverse phase chromatography, b) size exclusion chromatography, and c) hydrophobic interaction chromatography. Also provided is a manufacturing process for producing a glycoprotein of interest.

## Claims

### Claim 1

A process for the purification of a glycoprotein comprising subjecting a liquid containing the glycoprotein to the steps of:
a) reverse phase chromatography,
b) size exclusion chromatography, and
c) hydrophobic interaction chromatography.

### Claim 2 (depends on 1)

The process according to claim 1, wherein the steps are performed in the sequence of
(1) reverse phase chromatography,
(2) size exclusion chromatography, and
(3) hydrophobic interaction chromatography.

### Claim 3 (depends on 1)

The process according to claim 1, wherein in reverse phase chromatography step (a), the elution buffer contains an organic solvent.

### Claim 4 (depends on 1)

The process according to claim 1, wherein in size exclusion chromatography step (b), a buffer exchange is performed.

### Claim 5 (depends on 1)

The process according to claim 1, further comprising one or more steps selected from the group consisting of chromatography steps, filtration steps and virus inactivation steps.

### Claim 6 (depends on 1)

The process according to claim 1, further comprising one or more steps selected from the group consisting of ion exchange chromatography, affinity chromatography, diafiltration, ultrafiltration, nanofiltration and virus inactivation.

### Claim 7 (depends on 1)

The process according to claim 1, further comprising an anion exchange chromatography step.

### Claim 8 (depends on 7)

The process according to claim 7, wherein the anion exchange chromatography step is carried out subsequent to size exclusion chromatography step b).

### Claim 9 (depends on 7)

The process according to claim 7, wherein at least one salt-containing elution buffer is used in the anion exchange chromatography step.

### Claim 10 (depends on 7)

The process according to claim 7, wherein different charged isoforms of the glycoprotein are separated.

### Claim 11 (depends on 1)

The process according to claim 1, wherein the glycoprotein is selected from the group consisting of follicle-stimulating hormone (FSH), chorionic gonadotropin (CG), luteinizing hormone (LH) and thyroid-stimulating hormone (TSH).

### Claim 12 (depends on 1)

The process according to claim 1, wherein the glycoprotein is produced recombinantly.

### Claim 13

A process for the purification of a glycoprotein comprising subjecting a liquid containing the glycoprotein to the sequential steps of:
(0) Ultrafiltration:
(1) Reverse phase chromatography;
(1a) optionally Ultrafiltration;
(2) Size exclusion chromatography;
(3) Anion-exchange chromatography;
(4) Hydrophobic interaction chromatography;
(5) Ultrafiltration and/or diafiltration;
(6) Nanofiltration.

### Claim 14

A process for manufacturing a glycoprotein of interest, comprising the following steps:
i) recombinantly expressing the glycoprotein;
ii) purifying the glycoprotein by subjecting a liquid containing the glycoprotein at least to the steps of:
a) reverse phase chromatography,
b) size exclusion chromatography, and
c) hydrophobic interaction chromatography.

### Claim 15 (depends on 14)

The manufacturing process according to claim 14, further comprising one or more of the following steps:
(a) ion exchange chromatography;
(b) anion exchanged chromatography;
(c) affinity chromatography;
(d) ultrafiltration;
(e) diafiltration;
(f) nanofiltration; and
(g) virus inactivation.

### Claim 16 (depends on 14)

The manufacturing process according to claim 14, wherein the glycoprotein is a gonadotropin.

### Claim 17 (depends on 16)

The manufacturing process according to claim 16, wherein the gonadotropin is selected from the group consisting of FSH, CG, LH and TSH.

### Claim 18 (depends on 3)

The process according to claim 3, wherein the organic solvent is isopropanol.

### Claim 19 (depends on 11)

The process according to claim 11, wherein the glycoprotein is FSH.
